Indonesia-listed pharmaceutical company Phapros has received shareholders’ approval, during the August 26 extraordinary general meeting, to raise 1.1 trillion rupiah ($77.12 million) from a rights issue, reported Bisnis Indonesia.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
